Covid-19 Drug Racket: Pharma firm MD and 7 others busted

HYDERABAD: A Pharma firm MD and 7 othersin Hyderabad who were Black-marketing the covid-19 drugs were arrested by the Task Force. A chain of middlemen was used by the gang to supply drugs to patients.

K Venkata Subramanyam alias Phani, the MD of Sri Medicure Products (OPC) Private Limited, revealed that he procured drugs like Remdesivir and FabiFlu from the Hetero Pharma unit in Sangareddy district.

A drug, Tocilizumab, was also procured through Gagan Khurana (21), a Delhi- based supplier. Whatsapp platform was used by the gang and the business was running from past one month. The gang also accepted cash and UPI payment. “Drugs worth Rs 35 were seized from their possession”, according to Hyderabad Police Commissioner Anjani Kumar.
Police further said that, “K Venkata Subramanyam used to sold the drug first to Santosh Kumar. Afterwards, it changed many people till it reached the client. A margin of around Rs 4,000 were kept by each person. Inquiries also revealed that Remdesivir is available at Rs 5,400 per unit, but the gang members used to sale it for around Rs 40,000 and Tocilizumab which costs Rs 40,000 per unit, was being sold for more than Rs 1 lakh.

These drug is used to treat Covid-19 patients who are in the ventilator stage. Several patients who purchased the drug from the gang have been recovered. who Supplier of Tocilizumab to Phani, Gagan Khurana flew away to the city to deliver the medicines when he was arrested. Police officials are further investigating whether the gang supplied drugs in neighboring states as well.

  • Related Posts

    WHO launches new primary health care course to strengthen health systems globally

    Health is a human right – yet not everyone can access the health services they need, when and where they need them, without financial hardship. Primary health care (PHC) provides…

    Ayurveda needs stronger evidence, safety monitoring for market adoption, says CCRAS

    Bengaluru: The Central Council for Research in Ayurvedic Sciences (CCRAS) has called for stronger scientific evidence, safety monitoring and translation of research into market-ready technologies to improve the credibility and…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Excellence of Accredited Hospitals to be judged on how Friendly they are with Patients

    Excellence of Accredited Hospitals to be judged on how Friendly they are with Patients

    WHO launches new primary health care course to strengthen health systems globally

    WHO launches new primary health care course to strengthen health systems globally

    Ayurveda needs stronger evidence, safety monitoring for market adoption, says CCRAS

    Ayurveda needs stronger evidence, safety monitoring for market adoption, says CCRAS

    Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

    Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

    Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

    Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

    US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

    US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A